510(k) K251289

WELLlife COVID-19 Antigen Test Rx by Guangzhou Wondfo Biotech Co., Ltd. — Product Code QVF

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 22, 2025
Date Received
April 25, 2025
Clearance Type
Dual Track
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
Device Class
Class II
Regulation Number
866.3982
Review Panel
MI
Submission Type

A simple point-of-care device to detect SARS-CoV-2 viral targets directly from clinical specimens in near-patient settings is an in vitro diagnostic device for the direct detection of SARS-CoV-2 in clinical specimens and is intended as an aid in the diagnosis of SARS-CoV-2 infections COVID-19). The device is simple to use and does not involve sample manipulation, transportation of the sample to another functional area (e.g., a central laboratory or other specialized area), or measurement of reagents or analytes that could be affected by conditions such as sample turbidity or cell lysis. The design and procedures of the device are appropriate for use by healthcare professionals in near-patient settings outside a centralized laboratory